Table 2.
18–29 (n: 188) | 30–39 (n: 320) | 40–49 (n: 455) | 50–59 (n: 478) | 60–69 (n: 248) | 70–79 (n: 54) | 80–89 (n: 12) | P | |
---|---|---|---|---|---|---|---|---|
TSH (mIU/mL) | 5.5 ± 2.8 | 5.2 ± 3.5 | 5.1 ± 3 | 3.9 ± 0.4 | 3.03 ± 2 | 6.2 ± 2.1 | 4.8 ± 5.2 | 0.04 |
Duration of treatment (yrs) | 5 ± 3.7 | 4.6 ± 4 | 5.7 ± 4 | 6.2 ± 5.6 | 7.3 ± 6 | 8.2 ± 5.2 | 13.7 ± 9 | 0.04 |
Daily dose (µg/day) | 95.4 ± 49 | 95.7 ± 45 | 104 ± 56 | 91.3 ± 43 | 87.9 ± 39 | 94.9 ± 42 | 73.8 ± 35 | 0.001 |
Daily LT4 dosage (µg/kg) | 1.44 ± 0.8 | 1.51 ± 0.6 | 1.34 ± 0.6 | 1.72 ± 0.3 | 1.59 ± 0.2 | 1.24 ± 0.5 | 1.04 ± 0.4 | 0.001 |
Yrs, years; LT4, levothyroxine.